-
Company Profile
Plus Therapeutics Inc – Company Profile
Plus Therapeutics Inc (Plus Therapeutics), formerly Cytori Therapeutics Inc is a developmental-stage pharmaceutical company, which focuses on the discovery, development, and manufacturing of complex and innovative treatments for patients with cancer and other life-threatening diseases. The company’s pipeline of candidate drug products includes Doceplus, a patented albumin-stabilized Pegylated liposomal formulation of docetaxel; Doxoplus, a complex, injectable, generic Pegylated liposomal formulation of doxorubicin; BMEDA-chelated rhenium nanoliposome (RNL); and a co-encapsulated, doxorubicin and rhenium nanoliposome (DRNL). It uses a proprietary nanotechnology platform...
Add to Basket -
Product Insights
Myocardial Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Myocardial ischemia pipeline market research report provides comprehensive information on the therapeutics under development for Myocardial Ischemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Myocardial Ischemia and features dormant and...
-
Product Insights
Muscle Injury Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Muscle Injury Global Clinical Trials Review, H1, 2018" provides an overview of Muscle Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Fistula Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Fistula Global Clinical Trials Review, H2, 2017" provides an overview of Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by...
-
Product Insights
Hypertrophic Scars Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hypertrophic Scars Global Clinical Trials Review, H2, 2017" provides an overview of Hypertrophic Scars clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertrophic Scars. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Competitor Landscape: Systemic Sclerosis (Scleroderma)
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Systemic Sclerosis (Scleroderma) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Product Insights
Anal Fistula Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Anal Fistula Global Clinical Trials Review, H2, 2018" provides an overview of Anal Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Crohn’s Disease (Regional Enteritis) Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H1, 2019" provides an overview of Crohn's Disease (Regional Enteritis) clinical trials scenario. This report provides top line data relating to the clinical trials on Crohn's Disease (Regional Enteritis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2018" provides an overview of Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by...